SCHEMBL3277640

SCHEMBL3277640

CC=CCB(O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL837842 1.00
SCHEMBL838240 1.00
SCHEMBL1653664 0.73
SCHEMBL1653665 0.73
SCHEMBL8966546 0.72 TSHR (0.33)
SCHEMBL8966543 0.72 TSHR (0.33)
SCHEMBL17078171 0.69
SCHEMBL17078172 0.69
SCHEMBL11993618 0.69
SCHEMBL4384161 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250339401-A1 METHODS AND MATERIALS FOR TREATMENT OF NEISSERIA GONORRHOEAE INFECTION PURDUE RESEARCH FOUNDATION (US) 2025-11-06 US disclosed
US-20250195490-A1 ALPHA-METHYLENE AND AMINOMETHYL LACTONES AND LACTAMS FOR TREATMENT OF CLOSTRIDIOIDES DIFFICILE INFECTION (CDI) PURDUE RESEARCH FOUNDATION (US) 2025-06-19 US disclosed
US-12296045-B2 Copolymers for stabilizing emulsions and/or forming interfacial films, and methods thereof PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2025-05-13 US disclosed
EP-4536660-A1 NITROGEN CONTAINING CONDENSED 2,3-DIHYDROQUINAZOLINONE COMPOUNDS AS NAV1.8 INHIBITORS GlaxoSmithKline Intellectual Property Development Ltd (GB) 2025-04-16 EP disclosed
CN-119325476-A Nitrogen-containing condensed 2, 3-dihydroquinazolinone compounds as NAV1.8 inhibitors 葛兰素史密斯克莱知识产权发展有限公司 2025-01-17 CN disclosed
EP-4472961-A1 ALPHA-METHYLENE AND AMINOMETHYL LACTONES AND LACTAMS FOR TREATMENT OF CLOSTRIDIOIDES DIFFICILE INFECTION (CDI) Purdue Research Foundation (US) 2024-12-11 EP disclosed
EP-4313040-A2 METHODS AND MATERIALS FOR TREATMENT OF NEISSERIA GONORRHOEAE INFECTION Purdue Research Foundation (US) 2024-02-07 EP disclosed
WO-2023238065-A1 NITROGEN CONTAINING CONDENSED 2,3-DIHYDROQUINAZOLINONE COMPOUNDS AS NAV1.8 INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2023-12-14 WO disclosed
WO-2023150719-A1 ALPHA-METHYLENE AND AMINOMETHYL LACTONES AND LACTAMS FOR TREATMENT OF CLOSTRIDIOIDES DIFFICILE INFECTION (CDI) PURDUE RESEARCH FOUNDATION (US) 2023-08-10 WO disclosed
WO-2022204231-A2 METHODS AND MATERIALS FOR TREATMENT OF NEISSERIA GONORRHOEAE INFECTION PURDUE RESEARCH FOUNDATION (US) 2022-09-29 WO disclosed
US-20220241198-A1 COPOLYMERS FOR STABILIZING EMULSIONS AND/OR FORMING INTERFACIAL FILMS, AND METHODS THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2022-08-04 US disclosed
WO-2020242929-A1 COPOLYMERS FOR STABILIZING EMULSIONS AND/OR FORMING INTERFACIAL FILMS, AND METHODS THEREOF PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2020-12-03 WO disclosed
US-8207337-B2 Reagent for organic synthesis reaction containing organic triol borate salt WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2012-06-26 US disclosed
US-20100087646-A1 REAGENT FOR ORGANIC SYNTHESIS REACTION CONTAINING ORGANIC TRIOL BORATE SALT WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2010-04-08 US disclosed